Minoxidil is a medication used to treat hair loss, but it can be harmful if ingested. As required by the Poison Prevention Packaging Act, products like this must be sold in child-resistant packaging.

Cancer SIFs associated with increased risk for extrapulmonary cancer diagnosis in the year following an LDCT lung cancer screening exam.

Adoption of artificial intelligence (AI) scribes is linked to modest reductions in electronic health record (EHR) use and clinical documentation time, according ...

HealthDay News — Family physicians self-reporting burnout are almost 1.5 times more likely to leave or change practices than physicians not reporting burnout, according to a research letter published ...

Generic dapagliflozin is now approved for adults with type 2 diabetes, though current labeling excludes chronic kidney disease and pediatric use.

Robert F. Kennedy Jr. has released a new charter that expands the types of experts who can serve on the panel.

203 kava exposures reported in 2025; reports involving combined use of kava and kratom reached 30 percent of all kava reports in 2025 ...

FDA expands obesity treatment options with approval of oral semaglutide (Wegovy) and orforglipron (Foundayo), shifting GLP-1 therapy from weekly injections to daily pills.

The FDA is expected to decide on treatments for ADHD, Alzheimer disease, breast cancer, diabetes, and myasthenia gravis.

HealthDay News — Switching to integrase strand transfer inhibitors (INSTI) from protease inhibitors is associated with new diabetes risk in people with HIV, according to a study published online March ...

The TEPEZZA OBI trial evaluated the safety and efficacy of SC teprotumumab in patients with active TED and proptosis of 3mm or greater from baseline.

The once daily, oral glucagon-like peptide-1 receptor agonist was approved based on phase 3 data from ATTAIN-1 and ATTAIN-2.